Latest filing published 23 May 2025 for ACELYRIN, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Amar Murugan is a declared insider at 2 companies; the most frequent names are Atara Biotherapeutics, Inc. and ACELYRIN, Inc. The record holds 29 filings, for trades running from 20 April 2020 to 21 May 2025.
The open-market record consists of 22 sales worth €282k, with no purchase. Other entries cover 6 share grants. 2025 to date brings no purchases and 1 sale.
On 23 May 2025 came the latest disclosure, a transaction in ACELYRIN, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations